• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索布拉克帕金森病假说

Exploring Braak's Hypothesis of Parkinson's Disease.

作者信息

Rietdijk Carmen D, Perez-Pardo Paula, Garssen Johan, van Wezel Richard J A, Kraneveld Aletta D

机构信息

Division of Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Utrecht , Netherlands.

Division of Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands; Nutricia Research, Utrecht, Netherlands.

出版信息

Front Neurol. 2017 Feb 13;8:37. doi: 10.3389/fneur.2017.00037. eCollection 2017.

DOI:10.3389/fneur.2017.00037
PMID:28243222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5304413/
Abstract

Parkinson's disease (PD) is a neurodegenerative disorder for which there is no cure. Most patients suffer from sporadic PD, which is likely caused by a combination of genetic and environmental factors. Braak's hypothesis states that sporadic PD is caused by a pathogen that enters the body the nasal cavity, and subsequently is swallowed and reaches the gut, initiating Lewy pathology (LP) in the nose and the digestive tract. A staging system describing the spread of LP from the peripheral to the central nervous system was also postulated by the same research group. There has been criticism to Braak's hypothesis, in part because not all patients follow the proposed staging system. Here, we review literature that either supports or criticizes Braak's hypothesis, focused on the enteric route, digestive problems in patients, the spread of LP on a tissue and a cellular level, and the toxicity of the protein αSynuclein (αSyn), which is the major constituent of LP. We conclude that Braak's hypothesis is supported by , and clinical evidence. However, we also conclude that the staging system of Braak only describes a specific subset of patients with young onset and long duration of the disease.

摘要

帕金森病(PD)是一种无法治愈的神经退行性疾病。大多数患者患有散发性帕金森病,这可能是由遗传和环境因素共同导致的。布拉克假说认为,散发性帕金森病是由一种病原体引起的,该病原体通过鼻腔进入人体,随后被吞咽并到达肠道,从而在鼻腔和消化道引发路易体病理改变(LP)。同一研究团队还提出了一个描述LP从外周神经系统向中枢神经系统扩散的分期系统。对布拉克假说存在一些批评,部分原因是并非所有患者都遵循所提出的分期系统。在此,我们回顾了支持或批评布拉克假说的文献,重点关注肠道途径、患者的消化问题、LP在组织和细胞水平上的扩散,以及蛋白质α-突触核蛋白(αSyn)的毒性,αSyn是LP的主要成分。我们得出结论,布拉克假说得到了 和临床证据的支持。然而,我们也得出结论,布拉克的分期系统仅描述了疾病发病年龄较轻且病程较长的特定患者亚群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c83/5304413/cb0a8764f5ea/fneur-08-00037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c83/5304413/cb0a8764f5ea/fneur-08-00037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c83/5304413/cb0a8764f5ea/fneur-08-00037-g001.jpg

相似文献

1
Exploring Braak's Hypothesis of Parkinson's Disease.探索布拉克帕金森病假说
Front Neurol. 2017 Feb 13;8:37. doi: 10.3389/fneur.2017.00037. eCollection 2017.
2
[Braak's hypothesis and non-motor symptoms of Parkinson disease].[布拉克假说与帕金森病的非运动症状]
Brain Nerve. 2012 Apr;64(4):444-52.
3
Does Parkinson's disease start in the gut?帕金森病始于肠道吗?
Acta Neuropathol. 2018 Jan;135(1):1-12. doi: 10.1007/s00401-017-1777-8. Epub 2017 Oct 16.
4
Most cases with Lewy pathology in a population-based cohort adhere to the Braak progression pattern but 'failure to fit' is highly dependent on staging system applied.在基于人群的队列中,大多数具有路易体病理的病例符合 Braak 进展模式,但“不符合”高度依赖于所应用的分期系统。
Parkinsonism Relat Disord. 2019 Jul;64:124-131. doi: 10.1016/j.parkreldis.2019.03.023. Epub 2019 Mar 28.
5
Early-Onset Parkinson's Disease With Multiple Positive Intraoperative Spinal Tissue Cultures for Cutibacterium acnes.早发性帕金森病伴痤疮丙酸杆菌术中脊髓组织培养多次阳性
Cureus. 2021 Aug 31;13(8):e17607. doi: 10.7759/cureus.17607. eCollection 2021 Aug.
6
Examining Braak's hypothesis by imaging Parkinson's disease.通过影像学检查帕金森病来验证 Braak 假说。
Mov Disord. 2010;25 Suppl 1:S83-8. doi: 10.1002/mds.22720.
7
Non-CNS pathogenic origin of Parkinson's disease.帕金森病的非中枢神经系统发病原因。
J Neurol. 2017 Sep;264(9):2027-2030. doi: 10.1007/s00415-017-8588-7. Epub 2017 Aug 14.
8
The second brain and Parkinson's disease.第二大脑与帕金森病。
Eur J Neurosci. 2009 Sep;30(5):735-41. doi: 10.1111/j.1460-9568.2009.06873.x. Epub 2009 Aug 27.
9
Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?评估 Braak 假说:它能在多大程度上解释帕金森病的发病机制?
Expert Rev Neurother. 2012 Jun;12(6):673-86. doi: 10.1586/ern.12.47.
10
Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages.阿尔茨海默病中的嗅觉中枢:嗅球参与Braak早期阶段。
Neuroreport. 2001 Feb 12;12(2):285-8. doi: 10.1097/00001756-200102120-00021.

引用本文的文献

1
MicroRNAs and synaptic dysfunction in Parkinson's disease.帕金森病中的微小RNA与突触功能障碍
Mol Ther Nucleic Acids. 2025 Aug 12;36(3):102673. doi: 10.1016/j.omtn.2025.102673. eCollection 2025 Sep 9.
2
Adaptive immunity in the pathogenesis and treatments of Parkinson's disease.适应性免疫在帕金森病发病机制及治疗中的作用
NeuroImmune Pharm Ther. 2025 Jun 20;4(2):273-284. doi: 10.1515/nipt-2025-0008. eCollection 2025 Jun.
3
Understanding the Pre-Clinical Stages of Parkinson's Disease: Where Are We in Clinical and Research Settings?

本文引用的文献

1
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.由结合淋巴细胞激活基因3引发的病理性α-突触核蛋白传播。
Science. 2016 Sep 30;353(6307). doi: 10.1126/science.aah3374.
2
Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.综述:散发性帕金森病:α-突触核蛋白病理学的发展与分布
Neuropathol Appl Neurobiol. 2016 Feb;42(1):33-50. doi: 10.1111/nan.12298.
3
Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy.拮抗神经元Toll样受体2通过激活自噬预防突触核蛋白病
了解帕金森病的临床前期阶段:我们在临床和研究方面进展如何?
Int J Mol Sci. 2025 Jul 17;26(14):6881. doi: 10.3390/ijms26146881.
4
Resting-State EEG Alpha Asymmetry as a Potential Marker of Clinical Features in Parkinson's Disease.静息态脑电图α波不对称性作为帕金森病临床特征的潜在标志物
J Pers Med. 2025 Jul 4;15(7):291. doi: 10.3390/jpm15070291.
5
Parkinson's disease: exploring the systemic immune mechanisms through molecular investigations.帕金森病:通过分子研究探索全身免疫机制
Inflammopharmacology. 2025 Jun 23. doi: 10.1007/s10787-025-01816-9.
6
Metabolomic profiling uncovers diagnostic biomarkers and dysregulated pathways in Parkinson's disease.代谢组学分析揭示帕金森病的诊断生物标志物和失调通路。
Front Neurol. 2025 Jun 4;16:1608031. doi: 10.3389/fneur.2025.1608031. eCollection 2025.
7
The emerging role of microbiota derived SCFAs in neurodegenerative disorders.微生物群衍生的短链脂肪酸在神经退行性疾病中的新作用。
Brain Behav Immun Health. 2025 May 7;46:101012. doi: 10.1016/j.bbih.2025.101012. eCollection 2025 Jul.
8
Interplay of constipation, intestinal barrier dysfunction and fungal exposome in aetiopathogenesis of Parkinson's disease: hypothesis with supportive data.便秘、肠道屏障功能障碍与真菌暴露组在帕金森病病因发病机制中的相互作用:有支持性数据的假说
Biochem J. 2025 Jun 11;482(12):807-21. doi: 10.1042/BCJ20240621.
9
Association between functional gastrointestinal disorders and Parkinson's disease in a prospective cohort study.一项前瞻性队列研究中功能性胃肠疾病与帕金森病之间的关联
NPJ Parkinsons Dis. 2025 Jun 4;11(1):150. doi: 10.1038/s41531-025-01000-4.
10
APOE4-induced patterned behavioral decline and neurodegeneration requires endogenous tau in a model of Alzheimer's disease.在阿尔茨海默病模型中,APOE4诱导的典型行为衰退和神经退行性变需要内源性tau蛋白。
bioRxiv. 2025 May 15:2025.05.06.652574. doi: 10.1101/2025.05.06.652574.
Cell Rep. 2015 Oct 27;13(4):771-782. doi: 10.1016/j.celrep.2015.09.044. Epub 2015 Oct 17.
4
Exogenous α-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes.外源性α-突触核蛋白在星形胶质细胞中诱导Toll样受体4依赖性炎症反应。
BMC Neurosci. 2015 Sep 7;16:57. doi: 10.1186/s12868-015-0192-0.
5
Elevated neuronal α-synuclein promotes microglia activation after spinal cord ischemic/reperfused injury.神经元α-突触核蛋白水平升高促进脊髓缺血/再灌注损伤后的小胶质细胞活化。
Neuroreport. 2015 Aug 5;26(11):656-61. doi: 10.1097/WNR.0000000000000406.
6
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.靶向α-突触核蛋白治疗帕金森病:机制与治疗考量
Lancet Neurol. 2015 Aug;14(8):855-866. doi: 10.1016/S1474-4422(15)00006-X. Epub 2015 Jun 3.
7
Vagotomy and subsequent risk of Parkinson's disease.迷走神经切断术与帕金森病发病风险。
Ann Neurol. 2015 Oct;78(4):522-9. doi: 10.1002/ana.24448. Epub 2015 Jul 17.
8
Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.错误折叠的α-突触核蛋白激活MyD88依赖的TLR1/2信号通路,α-突触核蛋白是一种与神经退行性疾病相关的蛋白质。
Sci Signal. 2015 May 12;8(376):ra45. doi: 10.1126/scisignal.2005965.
9
Good vibrations with deep brain stimulation.深部脑刺激带来良好的震动效果。
Nat Neurosci. 2015 May;18(5):618-9. doi: 10.1038/nn.4007.
10
Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?帕金森病中的线粒体功能障碍与α-突触核蛋白突触病理学:谁先出现?
Parkinsons Dis. 2015;2015:108029. doi: 10.1155/2015/108029. Epub 2015 Mar 31.